GSK resolves remaining Zantac lawsuits by end of 2025? | Binary | | | 2 months ago | |
GSK records £1.8 billion charge in Q3 2024 results? | Binary | | | 2 months ago | |
GSK's Zantac settlement agreements finalized by June 2025? | Binary | | | 2 months ago | |
Will GSK finalize Zantac settlement agreements by June 30, 2025? | Binary | | | 2 months ago | |
Will GSK's stock price increase by 10% or more by December 31, 2024? | Binary | | | 2 months ago | |
What percentage of Zantac cases will GSK have settled by June 30, 2025? | Categorical | | | 2 months ago | |
Impact of Zantac settlements on GSK stock price by Q2 2025? | Categorical | | | 2 months ago | |
Outcome of ranitidine cancer risk assessment by end of 2025? | Categorical | | | 2 months ago | |
Resolution outcome of GSK's $70 million Qui Tam complaint by end of 2024? | Categorical | | | 2 months ago | |
Will GSK face new legal actions related to Zantac by December 31, 2024? | Binary | | | 2 months ago | |
What will be GSK's total financial impact from Zantac settlements by end of 2025? | Categorical | | | 2 months ago | |
How will Zantac settlements affect GSK's 2024 annual revenue? | Categorical | | | 2 months ago | |
